GGrantIndex
Sort

50,496 grants matching lung cancer

Administrative Supplement for Emory SeroNet "Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity"

$622,147
Ignacio E. Sanz · Emory University · U54 · FY2024 · CA

PATTERNS OF CARE STUDY IN RADIATION ONCOLOGY

$622,116
American College Of Radiology · R01 · FY2002 · CA

Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)

$622,074
Debra L Friedman · Vanderbilt University Medical Center · R01 · FY2023 · CA

Therapeutic/Toxic Effects of Electron Emitting Nuclides

$622,070
Amin I Kassis · Harvard Medical School · R01 · FY2010 · CA

Towards Translation of MU-CN29: New Therapeutic Nanoparticle for Drug-Resistant NSCLC

$622,068
Raghuraman Kannan · University Of Missouri-Columbia · R01 · FY2022 · CA

A Prospective Cohort Study of Patients with Non-Small Cell Lung Cancer and Multiple Myeloma to Assess the Benefits and Harms Related to Cannabis Use During Treatment

$622,059
Richard T Lee · Beckman Research Institute/City Of Hope · U01 · FY2023 · CA

Rhesus HHV-8 homologue in AIDS-related malignancies

$622,052
Scott W Wong · Oregon Health & Science University · R01 · FY2010 · CA

iPSC-based blood regenerative therapies for AIDS

$622,020
Igor I Slukvin · University Of Wisconsin-Madison · R01 · FY2013 · HL

Computer aided diagnosis of cancer metastases in the brain

$621,961
Xiaoyin Xu · Brigham And Women'S Hospital · R01 · FY2018 · LM

Pain and Symptoms of Cancer: Assessment and Treatment

$621,954
Charles S Cleeland · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA

Investigating Regulatory Networks that Control Cell Proliferation and Apoptosis

$621,900
Kurt Kohn · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Tumor Suppressor Gene Methylation in Lung Adenocarcinoma

$621,892
Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2009 · ES

MOLECULAR MECHANISMS OF CHRONIC AIRWAY AND ALVEOLAR DISEASE IN HIV

$621,875
Jeffrey J Atkinson · Washington University · U01 · FY2015 · HL

Risk-stratification of Prostate Cancers via Field Carcinogenesis Nanocytology

$621,871
Vadim Backman · Northwestern University · R01 · FY2016 · CA

Genetic Epidemiology of Lung Cancer

$621,844
Wayne State University · R01 · FY2005 · CA

Evaluation of genetic, clinical and environmental risk factors to establish effective screening strategies for second primary lung cancer

$621,799
Summer S Han · Stanford University · R37 · FY2024 · CA

Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA

$621,794
Douglas C Wallace · Children'S Hosp Of Philadelphia · R01 · FY2023 · CA

ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center

$621,608
Ticiana Leal · Emory University · UG1 · FY2023 · CA

Multilevel Interventions to Increase Adherence to Lung Cancer Screening

$621,529
Karen J Wernli · Kaiser Foundation Research Institute · R01 · FY2025 · CA

Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules

$621,526
Marc Elliott Lenburg · Boston University Medical Campus · R01 · FY2018 · CA

Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies

$621,510
Vito Quaranta · Vanderbilt University · R01 · FY2015 · CA

Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies

$621,510
Vito Quaranta · Vanderbilt University · R01 · FY2014 · CA

Radiomics of NSCLC

$621,495
Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2010 · CA

Novel therapeutics for the targeted eradication of DDR-defective tumors

$621,455
Seth B. Herzon · Yale University · R01 · FY2024 · CA

TAS::75 0872:: LUNG TISSUE RESEARCH CONSORTIUM: RADIOLOGY CENTER

$621,411
Brian Bartholmai · Mayo Clinic Rochester · N01 · FY2011 · HL